The Company’s cash balance as of December 31, 2023, was $56.6 million.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDSB:
- PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
- Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
- Is PDSB a Buy, Before Earnings?
- PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results
- PDS Biotechnology announces publication of research, patent grant